文献速递细菌感染、耐药与抗菌药物

芬兰小动物伪中间葡萄球菌耐药及MRSP分子流行病学研究

Antimicrobial resistance in Staphylococcus pseudintermedius and the molecular epidemiology of methicillin-resistant S. pseudintermedius in small animals in Finland.
PubMed 文献 · J Antimicrob Chemother · 2017-01-01

该研究分析了2011-15年芬兰临床伪中间葡萄球菌分离株的药敏数据,并对2010-14年362株MRSP进行PFGE分型、对87株代表株进行MLST和SCCmec分型。结果显示临床分离株中14%为MRSP,对其他抗菌药物耐药率在12%-39%之间,MRSP种群呈多样性,提示非克隆传播。

要点

  • 芬兰临床伪中间葡萄球菌中MRSP占14%,其他抗菌药物耐药率12%-39%。
  • MRSP种群多样,以CC71、CC45和CC258常见,提示非克隆传播。
  • 采样时使用抗菌药物、雄性及来自私人诊所与MRSP检出相关。

核心结论

  • 芬兰伪中间葡萄球菌耐药率高,强调感染控制措施和治疗前药敏试验的重要性。
  • MRSP种群多样,表明非克隆传播。

研究设计与样本

  • 分析2011-15年临床伪中间葡萄球菌分离株的药敏数据(n=1958,98%来自犬)。
  • 对2010-14年全部362株MRSP进行PFGE分型,对87株代表株进行MLST和SCCmec分型。
  • 使用logistic回归分析MRSP风险因素。

主要发现

  • 临床伪中间葡萄球菌中14%为MRSP,对其他抗菌药物耐药率在12%-39%之间,未观察到时间趋势。
  • MLST显示42种ST型,包括19种新ST型,CC71、CC45和CC258最常见,MRSP种群逐年多样化。
  • 采样时使用抗菌药物或雄性患者临床分离株更可能为MRSP;筛查标本中多药使用与MRSP检出相关;私人诊所标本MRSP检出可能性高于赫尔辛基大学教学医院。

临床怎么用

  • 治疗前应进行药敏试验,并加强感染控制措施以应对高耐药率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate antimicrobial susceptibility in Staphylococcus pseudintermedius and the occurrence of methicillin-resistant S. pseudintermedius (MRSP), to explore the molecular structure of the MRSP population and to analyse risk factors for MRSP. METHODS: Susceptibility data for clinical S. pseudintermedius isolates in 2011-15 were analysed using WHONET. All MRSP isolates in 2010-14 ( n = 362) were typed using PFGE. Representative isolates ( n = 87) of clusters were analysed using MLST and staphylococcal cassette chromosome mec (SCC mec ) typing. Risk factors were analysed using logistic regression. RESULTS: Of the clinical S. pseudintermedius ( n = 1958; 98% from dogs), 14% were MRSP. Resistance to other antimicrobials varied between 12% and 39%. No trends were observed over time. Among clinical specimens (from infection sites) and screening specimens (from potential carriers), respectively, 2.5% (267/10 813) and 9% (211/2434) revealed MRSP. MLST revealed 42 different STs, including 19 new ones. Clonal complexes 71, 45 and 258 were the most common, but the MRSP population diversified over the years. A clinical S. pseudintermedius isolate was more likely to be MRSP if the patient was on antimicrobials at the time of sampling or was male. The presence of MRSP in screening specimens was more likely if the patient was on multiple antimicrobials at the time of sampling. Specimens from private clinics (versus the Veterinary Teaching Hospital of the University of Helsinki) had a higher likelihood of MRSP in both analyses. CONCLUSIONS: Resistance to antimicrobials among S. pseudintermedius in Finland is high, emphasizing the importance of infection control measures and susceptibility testing prior to therapy. The diverse MRSP population indicates non-clonal spread.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Grönthal T, Eklund M, Thomson K, et al. Antimicrobial resistance in Staphylococcus pseudintermedius and the molecular epidemiology of methicillin-resistant S. pseudintermedius in small animals in Finland. J Antimicrob Chemother. 2017. PMID: 28065889. doi:10.1093/jac/dkw559

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。